1. Home
  2. EPIX vs ORMP Comparison

EPIX vs ORMP Comparison

Compare EPIX & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPIX
  • ORMP
  • Stock Information
  • Founded
  • EPIX 2009
  • ORMP 2002
  • Country
  • EPIX Canada
  • ORMP United States
  • Employees
  • EPIX N/A
  • ORMP N/A
  • Industry
  • EPIX Biotechnology: Pharmaceutical Preparations
  • ORMP Biotechnology: Pharmaceutical Preparations
  • Sector
  • EPIX Health Care
  • ORMP Health Care
  • Exchange
  • EPIX Nasdaq
  • ORMP Nasdaq
  • Market Cap
  • EPIX 76.8M
  • ORMP 90.7M
  • IPO Year
  • EPIX N/A
  • ORMP N/A
  • Fundamental
  • Price
  • EPIX $1.72
  • ORMP $2.15
  • Analyst Decision
  • EPIX Hold
  • ORMP Hold
  • Analyst Count
  • EPIX 3
  • ORMP 1
  • Target Price
  • EPIX $2.00
  • ORMP N/A
  • AVG Volume (30 Days)
  • EPIX 253.9K
  • ORMP 529.5K
  • Earning Date
  • EPIX 02-11-2025
  • ORMP 03-05-2025
  • Dividend Yield
  • EPIX N/A
  • ORMP N/A
  • EPS Growth
  • EPIX N/A
  • ORMP N/A
  • EPS
  • EPIX N/A
  • ORMP 0.11
  • Revenue
  • EPIX N/A
  • ORMP N/A
  • Revenue This Year
  • EPIX N/A
  • ORMP N/A
  • Revenue Next Year
  • EPIX N/A
  • ORMP N/A
  • P/E Ratio
  • EPIX N/A
  • ORMP $19.64
  • Revenue Growth
  • EPIX N/A
  • ORMP N/A
  • 52 Week Low
  • EPIX $1.40
  • ORMP $2.00
  • 52 Week High
  • EPIX $9.92
  • ORMP $3.67
  • Technical
  • Relative Strength Index (RSI)
  • EPIX 47.93
  • ORMP 39.89
  • Support Level
  • EPIX $1.69
  • ORMP $2.16
  • Resistance Level
  • EPIX $1.83
  • ORMP $3.09
  • Average True Range (ATR)
  • EPIX 0.07
  • ORMP 0.16
  • MACD
  • EPIX 0.01
  • ORMP -0.01
  • Stochastic Oscillator
  • EPIX 57.69
  • ORMP 4.08

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Share on Social Networks: